BRIEF-Bio-Techne Q3 Adjusted EPS USD 0.53 Vs. IBES Estimate USD 0.54

Bio-Techne Corporation

Bio-Techne Corporation

TECH

0.00

May 06 (Reuters) - Bio-Techne Q3 revenue USD 311.415 million vs. IBES estimate USD 317.1 million.

  • Q3 operating expenses USD 132.793 million
  • Q3 net income USD 51.047 million
  • Q3 operating income USD 75.495 million
  • Q3 pretax profit USD 71.225 million
  • Q3 EPS USD 0.32
This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.